Stocks that are trading heavily or have substantial price changes on Tuesday: PepsiCo, Palantir rise; Neogen, Akero Therapeutics fall.
The beverage and snack giant raised its profit forecast for the year.PepsiCo raises 2023 profit expectations as price hikes offset falling sales volumeThe banking company is reportedly considering selling its insurance brokerage unite to Stone Point.
The data-mining technology company was awarded a new contract with the U.S. Army.The video-gaming software company said CEO John Riccitiello is retiring.Investors were disappointed by the drug developer’s latest update on a potential liver condition treatment.The maker of windows and doors reportedly rejected a buyout offer from Miter Brands.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Stocks making the biggest moves premarket: Palantir, PepsiCo, Rivian and moreThese are the stocks posting the largest moves in premarket trading.
Lire la suite »
Akero Therapeutics shares plunge on liver disease treatment's mixed resultsCompany’s lead product candidate shows some benefit for patients with cirrhosis due to fatty liver disease
Lire la suite »
After-hours movers: Akero Therapeutics gains ahead of data, PagerDuty falls on conv. offeringAfter-hours movers: Akero Therapeutics gains ahead of data, PagerDuty falls on conv. offering
Lire la suite »
PepsiCo earnings top forecasts as price increases support profit boostPepsiCo added another round of price increases to its solid organic sales growth, allowing the drinks and snacks giant to lift its full year profit forecast for a third straight quarter.
Lire la suite »
PepsiCo lifts profit forecast again as price hikes fail to dent demandPepsiCo lifts profit forecast again as price hikes fail to dent demand
Lire la suite »
PepsiCo third-quarter core earnings per share top estimates amid price hikesPepsiCo third-quarter core earnings per share top estimates amid price hikes
Lire la suite »